1. Application of a Systems Pharmacology‐Based Placebo Population Model to Analyze Long‐Term Data of Postmenopausal Osteoporosis. (22nd August 2015) Authors: Berkhout, J; Stone, JA; Verhamme, KM; Stricker, BH; Sturkenboom, MC; Danhof, M; Post, TM Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 4:Number 9(2015:Sep.) Page Start: 516 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Disease Systems Analysis of Bone Mineral Density and Bone Turnover Markers in Response to Alendronate, Placebo, and Washout in Postmenopausal Women. (21st November 2016) Authors: Berkhout, J; Stone, JA; Verhamme, KM; Danhof, M; Post, TM Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 5:Number 12(2016:Dec.) Page Start: 656 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Model‐Based Characterization of the Pharmacokinetics of Pembrolizumab: A Humanized Anti–PD‐1 Monoclonal Antibody in Advanced Solid Tumors. (14th November 2016) Authors: Ahamadi, M; Freshwater, T; Prohn, M; Li, CH; de Alwis, DP; de Greef, R; Elassaiss‐Schaap, J; Kondic, A; Stone, JA Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 6:Number 1(2017) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Population Pharmacokinetic/Pharmacodynamic Modeling of Tumor Size Dynamics in Pembrolizumab‐Treated Advanced Melanoma. (29th November 2016) Authors: Chatterjee, MS; Elassaiss‐Schaap, J; Lindauer, A; Turner, DC; Sostelly, A; Freshwater, T; Mayawala, K; Ahamadi, M; Stone, JA; de Greef, R; Kondic, AG; de Alwis, DP Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 6:Number 1(2017) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗